Myriad Genetics, Inc.MYGNNASDAQ
Loading
Revenue PerformanceStable
Percentile Rank86
3Y CAGR+6.7%
5Y CAGR+8.2%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+6.7%/yr
vs -5.5%/yr prior
5Y CAGR
+8.2%/yr
Consistent
Acceleration
+12.2pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineStable
PeriodValueYoY Change
2025$824.50M-1.6%
2024$837.60M+11.2%
2023$753.20M+11.0%
2022$678.40M-1.8%
2021$690.60M+24.0%
2020$557.00M-12.8%
2019$638.60M-25.0%
2018$851.10M+10.2%
2017$772.60M+0.2%
2016$771.40M-